RNAZ
Price
$7.09
Change
+$0.06 (+0.85%)
Updated
Jun 4, 10:33 AM (EDT)
Capitalization
5.86M
TNXP
Price
$39.86
Change
-$0.59 (-1.46%)
Updated
Jun 4, 01:59 PM (EDT)
Capitalization
296.28M
68 days until earnings call
Interact to see
Advertisement

RNAZ vs TNXP

Header iconRNAZ vs TNXP Comparison
Open Charts RNAZ vs TNXPBanner chart's image
TransCode Therapeutics
Price$7.09
Change+$0.06 (+0.85%)
Volume$107
Capitalization5.86M
Tonix Pharmaceuticals Holding
Price$39.86
Change-$0.59 (-1.46%)
Volume$100
Capitalization296.28M
RNAZ vs TNXP Comparison Chart
Loading...
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNAZ vs. TNXP commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAZ is a Hold and TNXP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (RNAZ: $7.03 vs. TNXP: $40.45)
Brand notoriety: RNAZ and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAZ: 11% vs. TNXP: 89%
Market capitalization -- RNAZ: $5.86M vs. TNXP: $296.28M
RNAZ [@Biotechnology] is valued at $5.86M. TNXP’s [@Biotechnology] market capitalization is $296.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAZ’s FA Score shows that 1 FA rating(s) are green whileTNXP’s FA Score has 2 green FA rating(s).

  • RNAZ’s FA Score: 1 green, 4 red.
  • TNXP’s FA Score: 2 green, 3 red.
According to our system of comparison, TNXP is a better buy in the long-term than RNAZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAZ’s TA Score shows that 4 TA indicator(s) are bullish while TNXP’s TA Score has 3 bullish TA indicator(s).

  • RNAZ’s TA Score: 4 bullish, 3 bearish.
  • TNXP’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RNAZ is a better buy in the short-term than TNXP.

Price Growth

RNAZ (@Biotechnology) experienced а +2.26% price change this week, while TNXP (@Biotechnology) price change was +9.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.17%. For the same industry, the average monthly price growth was +4.97%, and the average quarterly price growth was -2.13%.

Reported Earning Dates

RNAZ is expected to report earnings on Apr 15, 2025.

TNXP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNXP($296M) has a higher market cap than RNAZ($5.86M). TNXP has higher P/E ratio than RNAZ: TNXP (0.11) vs RNAZ (0.00). TNXP YTD gains are higher at: 22.650 vs. RNAZ (-92.555). RNAZ has higher annual earnings (EBITDA): -16.19M vs. TNXP (-76.74M). TNXP has more cash in the bank: 55M vs. RNAZ (5.81M). RNAZ has less debt than TNXP: RNAZ (38.3K) vs TNXP (8.69M). TNXP has higher revenues than RNAZ: TNXP (11.3M) vs RNAZ (0).
RNAZTNXPRNAZ / TNXP
Capitalization5.86M296M2%
EBITDA-16.19M-76.74M21%
Gain YTD-92.55522.650-409%
P/E Ratio0.000.111%
Revenue011.3M-
Total Cash5.81M55M11%
Total Debt38.3K8.69M0%
FUNDAMENTALS RATINGS
TNXP: Fundamental Ratings
TNXP
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RNAZTNXP
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 6 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
RNAZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLPPX9.870.02
+0.20%
LDR Real Estate Value Opportunity P
MMKBX22.54N/A
N/A
Morgan Stanley Inst Emerging Mkts A
PNOCX82.22N/A
N/A
Putnam Sustainable Leaders C
MSCRX10.37N/A
N/A
Madison Small Cap R6
FZABX29.50N/A
N/A
Fidelity Advisor Diversified Intl Z

RNAZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAZ has been loosely correlated with NGNE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RNAZ jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAZ
1D Price
Change %
RNAZ100%
-0.92%
NGNE - RNAZ
48%
Loosely correlated
+15.83%
ABCZF - RNAZ
37%
Loosely correlated
N/A
BPTSY - RNAZ
33%
Poorly correlated
N/A
AGEN - RNAZ
32%
Poorly correlated
+21.07%
EDSA - RNAZ
31%
Poorly correlated
N/A
More